IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v15y2024i1d10.1038_s41467-024-46694-x.html
   My bibliography  Save this article

Maternal hybrid immunity and risk of infant COVID-19 hospitalizations: national case-control study in Israel

Author

Listed:
  • Joshua Guedalia

    (Faculty of Medicine of the Hebrew University of Jerusalem)

  • Michal Lipschuetz

    (Faculty of Medicine of the Hebrew University of Jerusalem
    Henrietta Szold Hadassah Hebrew University School of Nursing in the Faculty of Medicine Jerusalem
    The Jerusalem Center for Personalized Computational Medicine Jerusalem)

  • Adva Cahen-Peretz

    (Faculty of Medicine of the Hebrew University of Jerusalem)

  • Sarah M. Cohen

    (Faculty of Medicine of the Hebrew University of Jerusalem)

  • Yishai Sompolinsky

    (Faculty of Medicine of the Hebrew University of Jerusalem)

  • Galit Shefer

    (Israel Ministry of Health)

  • Eli Melul

    (Israel Ministry of Health)

  • Zivanit Ergaz-Shaltiel

    (Faculty of Medicine of the Hebrew University of Jerusalem)

  • Debra Goldman-Wohl

    (Faculty of Medicine of the Hebrew University of Jerusalem)

  • Simcha Yagel

    (Faculty of Medicine of the Hebrew University of Jerusalem)

  • Ronit Calderon-Margalit

    (Faculty of Medicine of the Hebrew University of Jerusalem)

  • Ofer Beharier

    (Faculty of Medicine of the Hebrew University of Jerusalem
    The Jerusalem Center for Personalized Computational Medicine Jerusalem)

Abstract

Hybrid immunity, acquired through vaccination followed or preceded by a COVID-19 infection, elicits robust antibody augmentation. We hypothesize that maternal hybrid immunity will provide greater infant protection than other forms of COVID-19 immunity in the first 6 months of life. We conducted a case-control study in Israel, enrolling 661 infants up to 6 months of age, hospitalized with COVID-19 (cases) and 59,460 age-matched non-hospitalized infants (controls) between August 24, 2021, and March 15, 2022. Infants were grouped by maternal immunity status at delivery: Naïve (never vaccinated or tested positive, reference group), Hybrid-immunity (vaccinated and tested positive), Natural-immunity (tested positive before or during the study period), Full-vaccination (two-shot regimen plus 1 booster), and Partial-vaccination (less than full three shot regimen). Applying Cox proportional hazards models to estimate the hazard ratios, which was then converted to percent vaccine effectiveness, and using the Naïve group as the reference, maternal hybrid-immunity provided the highest protection (84% [95% CI 75-90]), followed by full-vaccination (66% [95% CI 56-74]), natural-immunity (56% [95% CI 39-68]), and partial-vaccination (29% [95% CI 15-41]). Maternal hybrid-immunity was associated with a reduced risk of infant hospitalization for Covid-19, as compared to natural-immunity, regardless of exposure timing or sequence. These findings emphasize the benefits of vaccinating previously infected individuals during pregnancy to reduce COVID-19 hospitalizations in early infancy.

Suggested Citation

  • Joshua Guedalia & Michal Lipschuetz & Adva Cahen-Peretz & Sarah M. Cohen & Yishai Sompolinsky & Galit Shefer & Eli Melul & Zivanit Ergaz-Shaltiel & Debra Goldman-Wohl & Simcha Yagel & Ronit Calderon-M, 2024. "Maternal hybrid immunity and risk of infant COVID-19 hospitalizations: national case-control study in Israel," Nature Communications, Nature, vol. 15(1), pages 1-9, December.
    • Handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-46694-x
    DOI: 10.1038/s41467-024-46694-x
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-024-46694-x
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-024-46694-x?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Joshua Guedalia & Michal Lipschuetz & Ronit Calderon-Margalit & Sarah M. Cohen & Debra Goldman-Wohl & Tali Kaminer & Eli Melul & Galit Shefer & Yishai Sompolinsky & Asnat Walfisch & Simcha Yagel & Ofe, 2022. "Effectiveness of a third BNT162b2 mRNA COVID-19 vaccination during pregnancy: a national observational study in Israel," Nature Communications, Nature, vol. 13(1), pages 1-7, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Elisabeth A. Murphy & Camila Guzman-Cardozo & Ashley C. Sukhu & Debby J. Parks & Malavika Prabhu & Iman Mohammed & Magdalena Jurkiewicz & Thomas J. Ketas & Sunidhi Singh & Marie Canis & Eva Bednarski , 2023. "SARS-CoV-2 vaccination, booster, and infection in pregnant population enhances passive immunity in neonates," Nature Communications, Nature, vol. 14(1), pages 1-10, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-46694-x. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.